Matthew Shinkle is an Online Content Editor at Healio, where he specializes in medicine and healthcare, focusing on topics such as oncology, immunology, and palliative care. With a background in sports journalism and a passion for medical reporting, he brings a unique perspective to his work. Shinkle's insights have been featured in Haddonfield Sun, Healio, and LessWrong 2.0.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Matthew Shinkle's coverage predominantly revolves around healthcare and pharmaceuticals, focusing on scientific research and data-driven insights. Given the emphasis on citing data, pitches to him should provide robust scientific evidence or studies that uncover significant advancements or disparities in cancer treatment. Additionally, given his focus on racial disparities and drug therapy, he may be interested in stories concerning innovative approaches to addressing these issues.
Sources with a deep understanding of clinical trials and medical research could effectively engage Matthew through providing valuable context for new therapies, especially those related to breast cancer, lymphoma, or drugs targeting specific patient populations.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Matthew Shinkle
CHICAGO — Duodenal mucosal resurfacing helped prevent weight regain following tirzepatide discontinuation, according to research presented at Digestive Disease Week.Data from the randomized REMAIN-1 trial showed that individuals who did not undergo duodenal mucosal resurfacing (Revita, Fractyl Health) regained approximately 40% more weight than those who received the investigational
By: Matthew Shinkle
CHICAGO — Sharp differences in mortality rates and costs related to alcohol-associated hepatitis before and after the COVID-19 pandemic highlight persistent demographic and socioeconomic disparities, according to a study.Results of the retrospective cohort study showed disproportionate increases in mortality rates among Native American and Hispanic individuals, and higher hospital charges
By: Heather Biele, Matthew Shinkle
CHICAGO — Wearable device-derived sleep metrics may help monitor inflammatory bowel disease activity and response to biologic therapy, according to research presented at Digestive Disease Week.
By: Heather Biele, Matthew Shinkle
CHICAGO — Patients with irritable bowel syndrome who consumed an elemental diet for 2 weeks reported significant improvement in abdominal
By: Heather Biele, Matthew Shinkle
CHICAGO — The number of annual colonoscopies performed in the U.S. is projected to decline over the next decade as use of noninvasive colorectal
By: Matthew Shinkle
CHICAGO — Early treatment with infliximab and an immunomodulator was associated with more than five times reduced risk for abdominal surgery at 5 years among patients with newly diagnosed Crohn’s disease, according to a presenter.Follow-up PROFILE trial data presented at Digestive Disease Week showed that early control of inflammation during a 48-week treatment period also lowered
By: Matthew Shinkle, Heather Biele
The FDA has approved an oral combination therapy for certain adults with newly diagnosed acute myeloid leukemia.
By: Matthew Shinkle
CHICAGO — Even as colorectal cancer screening rates have risen among older adults across race and ethnicity, racial disparities in cancer screenings have not improved comparatively, according to data presented at Digestive Disease Week.An analysis of 2015-2023 National Health Interview Surveys showed that despite an annual 1.6% increase in CRC screening overall, individuals who identify as
By: Matthew Shinkle
Several nonantibiotic drugs appear associated with increased risk for Clostridioides difficile infection, according to results of a population-based, case-control study published in Gut.An analysis of data from the Swedish National Patient registry showed antidiarrheals, analgesics and corticosteroids were among nonantibiotic drugs associated with increased risk for C. difficile infection. They
By: Heather Biele, Matthew Shinkle
A text message reminder-based strategy significantly improved colorectal cancer screening rates among adults in underserved communities, compared with nurse-led telephone call outreach, according to study results.
